Molecular diagnostics firm Seegene is to unveil its fully automated PCR testing system, CURECA, and data analytics platform, STAgora, at ADLM 2025.
A live demonstration of CURECA (pictured) will take centre stage of the company’s presence at the Association for Diagnostics & Laboratory Medicine (ADLM) event, the world's largest diagnostics conference, taking place in Chicago, USA on 28-31 July.
CURECA is the world's first system to fully automate the entire PCR testing process – from sample storage and pre-treatment to nucleic acid extraction, amplification, and result analysis – without any human intervention. Designed for 24/7 continuous operation, the system minimises human error and dramatically improves the consistency and reliability of the test results.
A key breakthrough lies in its fully automated prep module, which addresses one of the most burdensome and error-prone stages in laboratory workflows. Pre-treatment has traditionally been a major challenge, particularly when dealing with diverse sample types such as urine, blood, sputum, and stool. Laboratory technicians often carry out repetitive manual tasks over extended hours, and variations in skill level can result in inconsistent outcomes. Stool samples, especially, have posed serious automation barriers due to their high viscosity and particulates, requiring heavy manual handling.
The prep module of the CURECA system is the first to fully automate pre-treatment process across all major sample types – including stool – overcoming longstanding obstacles in laboratory operations. This innovation reduces labour demands, expands sample throughput, and enhances overall operational and cost efficiency. It also shifts the role of laboratory personnel from manual processing to higher-level responsibilities, such as data analysis and clinical interpretation – helping laboratories better leverage their workforce in high volume, 24/7 continuous testing environments to provide sustainable high quality testing results.
In addition, CURECA’s prep module has applications beyond PCR diagnostics. It supports pre-treatment for other disciplines, including clinical chemistry and immunoassays, marking a significant step forward in automation across the broader diagnostics market. Its modular architecture allows for flexible configuration and deployment tailored to the size, layout, and needs of each laboratory.
Also unveiled at ADLM 2025, STAgora is Seegene's statistical platform that collects and analyses real-time PCR diagnostic data to support clinical decision-making. By aggregating test data uploaded from hospitals around the world, the platform provides integrated insights into regional infection trends, hospital-level positivity rates, and patterns of co-infection. It also offers more than 40 statistical tools tailored for clinical support.
With STAgora, healthcare providers can compare individual patient test results with local and regional epidemiological data, enabling more precise, data-driven treatment strategies. The platform allows clinicians to evaluate infection trends at both patient and community levels, improving the accuracy and speed of diagnosis and care planning.